These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nebulised ribavirin for influenza B viral pneumonia in a ventilated immunocompromised adult. Bell M; Hunter JM; Mostafa SM Lancet; 1988 Nov; 2(8619):1084-5. PubMed ID: 2903314 [No Abstract] [Full Text] [Related]
7. Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. Smith CB; Charette RP; Fox JP; Cooney MK; Hall CE J Infect Dis; 1980 May; 141(5):548-54. PubMed ID: 7373088 [TBL] [Abstract][Full Text] [Related]
9. [New therapeutic strategies in influenza infections in patients at risk. Controlled study of ribavirin]. Pellegrino M; Baldini EV; Amorico MG; Bisetti A Clin Ter; 1987 Jul; 122(1):25-31. PubMed ID: 2973893 [No Abstract] [Full Text] [Related]
10. Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers. Magnussen CR; Douglas RG; Betts RF; Roth FK; Meagher MP Antimicrob Agents Chemother; 1977 Oct; 12(4):498-502. PubMed ID: 921245 [TBL] [Abstract][Full Text] [Related]
11. Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Wilson SZ; Gilbert BE; Quarles JM; Knight V; McClung HW; Moore RV; Couch RB Antimicrob Agents Chemother; 1984 Aug; 26(2):200-3. PubMed ID: 6486761 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza. Salido-Rengell F; Nasser-Quinones H; Briseno-Garcia B Ann N Y Acad Sci; 1977 Mar; 284():272-7. PubMed ID: 360901 [TBL] [Abstract][Full Text] [Related]
13. Biochemistry and clinical applications of ribavirin. Gilbert BE; Knight V Antimicrob Agents Chemother; 1986 Aug; 30(2):201-5. PubMed ID: 2876677 [No Abstract] [Full Text] [Related]
14. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis. Ray CG; Icenogle TB; Minnich LL; Copeland JG; Grogan TM J Infect Dis; 1989 May; 159(5):829-36. PubMed ID: 2775346 [TBL] [Abstract][Full Text] [Related]
15. Comparison of oral and aerosol ribavirin regimens in the high risk elderly. Bernstein JM; Liss H; Erk SD J Clin Pharmacol; 1989 Dec; 29(12):1128-34. PubMed ID: 2693503 [TBL] [Abstract][Full Text] [Related]
16. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus. Togo Y; McCracken EA J Infect Dis; 1976 Jun; 133 Suppl():A109-13. PubMed ID: 778306 [TBL] [Abstract][Full Text] [Related]
17. Ribavirin aerosol treatment of influenza B virus infection. McClung HW; Knight V; Gilbert BE; Wilson SZ; Quarles JM; Couch RB; Divine GW; Gordon WH; Thurston JM; Atmar RL Trans Assoc Am Physicians; 1983; 96():284-93. PubMed ID: 6093312 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of the antiviral preparation ML-76 in influenza]. Iakushin AI; Trantseeva TB Tr Inst Im Pastera; 1985; 63():42-7. PubMed ID: 3916352 [No Abstract] [Full Text] [Related]
20. [Comparative evaluation of the therapeutic effectiveness of virazole and remantadine in patients with influenza caused by A(H3N2) and B viruses]. Kolobukhina LV; Krylov VF; Grushinskaia IA; Ivanova LA; Poliakova TG Vopr Virusol; 1985; 30(3):296-8. PubMed ID: 4049841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]